Carrington Trust Boosts Stake in BCAL Diagnostics

BCAL Diagnostics Limited (AU:BDX) has released an update.

Capital Property Corporation Pty Ltd, acting as trustee for the Carrington Trust, has increased its voting power in BCAL Diagnostics Limited from 6.40% to 7.54% through a series of market purchases, acquiring a total of 7,500,000 ordinary shares. The substantial increase in shares, detailed in a recent disclosure, highlights the trust’s growing investment in the diagnostic company.

For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.